Table 5.
Patient, stimulator cells | Allogeneic proliferation stimulation index |
---|---|
1 | |
Uninfected | 1.0 |
MVA-WT | 1.3 |
MVA-TRICOM | 131.0 |
2 | |
Uninfected | 0.6 |
MVA-WT | 0.7 |
MVA-TRICOM | 121.8 |
4 | |
Uninfected | 0.6 |
MVA-WT | 0.8 |
MVA-TRICOM | 68.6 |
16 | |
Uninfected | 11.7 |
MVA-WT | 9.4 |
MVA-TRICOM | 34.4 |
17 | |
Uninfected | 2.9 |
MVA-WT | 2.9 |
MVA-TRICOM | 179.6 |
18 | |
Uninfected | 9.0 |
MVA-WT | 3.1 |
MVA-TRICOM | 35.8 |
CD3+ T cells from healthy donors were stimulated with uninfected, MVA-WT– or MVA-TRICOM–infected CLL cells, at a ratio of stimulator to effector cells equal to 1:10. Proliferation was measured as 3H-thymidine incorporation on day 5 of culture. Stimulation index was calculated as cpm (T cells + CLL cells)/cpm (T cells alone).